Mutation of the K-ras oncogene is a common event in the early development of pancreatic cancer occurring in 95% of pancreatic cancers, with a resulting overall increase in production of reactive oxygen species (ROS) [3]. Here, KRAS is linked to familial pancreatic carcinoma.